Dynavax Technologies Awarded Grant to Discover Viability of Universal Papilloma Virus Vaccine

Dynavax Technologies Awarded Grant to Discover Viability of Universal Papilloma Virus Vaccine

posted in: Emailwire.com Stock News by On July 7th, 2010

(EMAILWIRE.COM, July 07, 2010 ) Cheyenn, WY – The company Dynavax Technologies Corporation (NASDAQ: DVAX) made an announcement today that a grant of worth $600,000 has been awarded from the National Institutes of Health. This is for the viability exploration and development of vaccine for prevention…
Original post here Email Wire Press Releases

For hot penny stock picks, daily small cap alerts, and stock market news alerts visit http://www.stockorange.com

Comments are closed.